Catalyst Pharmaceuticals Inc. CPRX shares are trading higher by 6.40% to $16.12 Tuesday after it was announced the company will join the S&P SmallCap 600.
Catalyst Pharmaceuticals will replace Mantech International Corp. MANT in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15.
The Carlyle Group Inc. CG is acquiring ManTech International in a transaction expected to be completed soon pending final conditions.
According to data from Benzinga Pro, Catalyst Pharmaceuticals has a 52-week high of $17.22 and a 52-week low of $4.81.
Image and article originally from www.benzinga.com. Read the original article here.